Global HPV Action Plan
The Consortium’s Action Plan seeks to respond to the needs and challenges that countries and communities face to make cervical cancer history.
Sabin Launches the Global HPV Consortium
Mobilizing a transdisciplinary movement to prevent HPV and end cervical cancer.
HPV Factsheet
A snapshot of datapoints that underline the need for this Consortium.
Join the consortium
Be a part of the Consortium’s growing public and private sector collaboration and contribute in a variety of ways to the ongoing efforts to prevent HPV and cervical cancer.
An increased sense of urgency is needed as the world falls behind
Since introduction in 2006, HPV vaccines have proven safe and effective in protecting against infection and preventing cervical cancer. Yet, the burden of HPV diseases continues to rise with an estimated 600,000 new cases of cervical cancer and over 340,000 deaths each year.
To respond to these life-threatening trends, the Sabin Vaccine Institute, as consortium secretariat, along with a diverse, and expanding, set of partners will mobilize action across three pillars:
The Global HPV Consortium will be guided by global goals, including WHO’s Immunization Agenda 2030 and Cervical Cancer Elimination Initiative:
Who We Are
Global HPV Action Plan
The Consortium’s Action Plan seeks to respond to the needs and challenges that countries and communities face to make cervical cancer history. The action plan will encompass four key areas:
- Advocacy and Thought Leadership
- Knowledge Management and Exchange
- Convening of Key Stakeholders
- Country-Based Support
Be a part of the Consortium’s growing public and private sector collaboration